Pneumonie a Pneumocystis carinii associec au VIH -lnvestiguer ou seulement trailer? RJ;;suMf: : I.a pncu monic a 1'11/'ltll/(IC_\'.)lis rnrinii tPPC) IN llllC manifc,tation trc\ cour;inte uu ,yndromc d'immumx1~11cicnL·c a1:qui,c (S I DA) et r6ultc de I' in fec tion par I..: virus de 1 · i 111111u111lc.lc1icicncc humainc ( Y II I). La plupart de, cpi, ode, ,e rrc,cntcnt d'unc 111:111icrc plu1Gt 1ypiq ue: t.l yspncc progr..:,siv c clfou 1011x 11011 product ive. i11fil1ratio11, i111crs1 i1icllc, uiffu,c, rcvelcc, par la fa · diographie pulmonairc ct elevation du gr,1dicnt alvfolo-arti:ricl en oxygt'.:nc. Cc tableau e,1 , i rcprc,c1 11a1i f de l'affec1inn quc le, omn ipraticicn, dcbu1cnt ,ou,·cnt un traitcmcn t empiriquc san, prcu ,·c microbiol ogiquc de la maladie. Celle , tr.llcgic n·a jamai, etc \ alidcc par de., cssa i, di niq uc, c;ontrci lc, hicn quc d1:, modt'.:lcs analytiquc, deei,ionncl, aicnt tc111c de l'cvalucr. Le d1oix t. 1 'ad-mi11 i,1rcr un tr.titcmcnt a11ti111icrohic n ,ur unc ha,c empiriquc e, 1 ,urcrncm fo ndc dan, certai n, contcxtc, clin iquc, ,pccifiquc, te h quc (al image rac.liologiquc typiquc ehe, unc pcr~onnc pr6cntant unc c.ly,pn6c ct/ou unc toux 111 n1 prouuctivc, prc,cnce du YI 11 ct numeration c.lcs C'l)-4 inli:ricure ~ 200 ccll ulevmn/: (b) Pl'C antcricure. apparencc 1ypiquc ct pat ient connu pour , a tolfranec au trnitcm<.:nl sianuard a111i-1-'PC cl ( t: ) index de ,u,picion eliniquc clcvc chc, un p,11ic111 qui rcfu,<.: unc hrond 10,copic ct demandc un tia i1crnc11t ou lor-.~1u'i l c,t i111po,.,ihlc de pr.H iqucr unc hroncho-,copic. Ccpcndant. i i c,t f,irtcmcnt rccommanuc lie pra1iquer rapidcrncnt unc h1 oncho,copic h>r"-)UC la radiographic pulmonaire n·c,t pa, caractcri,1 iquc d" unc infection It I'. rnri11ii nu ,i le paticm llC rcponu r a, au traitcrncnl aprc, UllC pcriodc prcdctermint:e. e ig ht to 10 million cases of infec tion with the human immunode ficiency virus (H IV ) in the worl d, of which over one million have progressed to the acquired imm unodeficiency syndrome (AIDS) (I). Respiratory di sease is the most com mon initial manifestation of AIDS. with !'11e11111oc,·stis carinii p11L·umo nia (PCP) accounting for the majori ty of respiratory presentations. As experience has increased over the yea rs with what can be a fairly ·typical" presentatio n, the Cente rs for Disease Control and Prevention (CDC ) has recogni zed that many patients are being treated for PC P witho ut a confirmed diag nosis and have there fore revised the d iagnostic criteri a for the definition of A IDS for surveillence pu rposes. AIDS can be di agnosed on the basis o f a presu m ptive di ag nosis of PCP when the patient with HIV presents with the new onset of dyspnea on exertion or nonproduct ive cough. a diffuse interstitial pattern on chest radiograph. e lev:Hed alveo lar-arterial oxygen gradient and no evidence of bacterial pneumonia (2). Despite the C DC accepting a presumed diagnosis of PCP fo r the categorization of AIDS, the CDC docs not appear to endorse wholeheartedly empirical treatment.
In the earl y ye ars of management of H IV infected patients, microbiolog ical proof of infection with P rnrinii was so ught in vi rtually all patie nts. However. a strong argument can be made fo r empirical treatment based on clinical and radiographic suspicion of PC P. As well, there are invest ig ations that can be initiated to rai se or lower clinical suspicion g iven a hi story and chest racliograph compatible wi th PCP. T he li kelihood of PC P increases sign ifica ntly when the CD4 count falls below 200 cells/11111/ T he likelihood of PCP in the infected patient not receiv ing AZT ( Lidovudinc) or pneumocystis prophylax is gi ven a compatible history and 
BRONCHOSCOPYVERSUS EMPIRICAL THERAPY
The most direct method for obtaining an adequate sample is fibreoptic bronchoscopy with bronclwal vL'olar la vage. T he sens itivity of bronchoscopy with bronchoa lvcol ar lavage exceed s 90% in vi rtuall y all studies. T he spcL' ilic ity is obviously e xcelle nt. T rans bro nc hial bi o psies add potential morbidi ty with little g a in in se ns iti vity . T he adva nt ages of ea rl y fibreopti c bronchoscopy include the ability to find other potential in fec tive agen ts tha t could be treatL'd , and not subj ecting a pati e nt to the potential and frequent side e ffcL'ts of ant imic robial the rapy for PC P. Furt he rmore . w he n the use or tri me th op rim-sulphamethox azo le is limited due to previous ad verse side effec ts. the a lternative agents (cg. pent a midine or the combination of clindamyc in and primaquine) do nut carry the broad antibacteri a l spec trum or trimcthoprim-s ulphamcthoxazole . An incorrectl y diagnosed episode of PCP may lead to m isdi ag nos ing so meone as having AIDS rather than si m pl y carry ing H IV. The d iagnosis of AI DS carri es a g reat psychological burdC'n as we ll as the potential addition of therapy with toxic and often un proven agents. Fina lly, it would be far simp ler, with less morbidity, tu conduct hron choscopy on a pati ent with mild disturbances in gas e xc hange rather tha n atte mpting bronc hoscopy in the patie nt who has deve lo ped severe respiratory distress follow ing failure uf anti -PCP age nts.
T he advantage o f foregoing brnnchoscopy and initiating e mpirical the rapy incl ude a sio nificant cost saving, e liminating d iscomfort related to bronchoscopy and not subject ing medical personnel tu the risk of contamination with inrectcd body tluids.
A recent publication approac hed the quL'stion or bronchoscopy versus empi rical the rapy using the technique of ckcisiun ana lysis (6). The model was based \HI a patient not receiving pneu moc ys tis prophylaxi s presen ting with criteria sati sfactory for the CDC diagnosis of presumed PCP. Early bronchoscopy wi th treat me nt based on the brnnchoscopy results was compared with e mpirical treatment for PCP (trimethoprim-sulfametho xazolc o r pentam idine, and steroids) and clelayccl bronchoscopy in those not re sponding to fiv e clays o f tre atment. There was essenti a lly no d ifference in the ex pected one-month survival rates comparing both ma nageme nt strategics. T herefore. it was concluded tha t emp irical treatme nt would be a su perior strategy in thal specific sn:nario. gi ven that early bronchoscopy did not offer any addi tional survival bene fi t and was associated with additional costs and discomfort with possible morbidity to the patient. Unfo11unately, the study used bronchoscopy with hronchoalveolar lavage and tra nsbronchial biopsies. One could argue that transbronchial biopsies are not necessary, and there fo re not using them would decrease morbidity. As well, the study did not use a model in which patients received pncurnocystis prophyl axis, which would lower the estimated prior probability of PCP. lt could be argued that with aggressive use of trimethoprim-sulphamcthoxazole prophylaxis and the knowledge that it is a better prophylactic agent than aerosoli zed pcntamidine, empirical therapy should not be initi ated in those patients tolerating trimethoprim-sulphamethoxazole prophylaxis even when the clinical scenerio is highly suggestive of PCP. Nevertheless, the study is extremely use ful and provides obj ective information for empirical treatment initiall y. with bronchoscopy reserved for those who fail to respond appropriately within fi ve days.
Systemic corticosteroids are now accepted as part of standard therapy for patients with PCP and a Pa02 of less than 70 mmHg (7) . If empirical therapy is instituted in such a scenerio it behooves the physician to also prescribe corticosteroids . The advantages have been adequately documented in several tri ab when the diagnosis is certain (8-10). While the study by Tu and colleagues (6) included steroid therapy. they did not factor in potential morbidity. Generally, a limited course of corticosteroids is well tolerated but the potential ex ists for acceleration of respiratory illness when the cause of the disorder is an infecting organism other than P carinii. As well, a history of glucose intolerance will likely influence the prescription of empiri cal therapy and corticosteroids.
Thi s entire debate may be somewhat irrelevant as empirical therapy is the standard of care for many physicians. A survey of 463 respirologists in the United Kingdom questioned manageme nt strategies in patients with HIV. Two hundred and sixty-six phys ici ans responded, with two-th irds choosing empi rical treatment of PCP over immediate fi breoptic bronchoscopy ( 1 l ).
While each case should be indi vidualized, empirical treatment with antibiotics against P rnrinii is a reasonable option under the following scenarios:
• Typical radiographic picture in a person with dyspnea and/or nonproductive cough, HIV and a CD4 count less than 200 cells/mm 3 , whether or not the per~on is receiving antiretrovi ral therapy or PCP prophylaxis.
• Previous PCP, typical appearance and the patient is known to tolerate standard anti-PCP medications.
• High clinical suspicion in a patient who refuses bronchoscopy yet desires treat ment, or where bronchoscopy cannot be performed.
Empirical therapy alone should not be initiated when the chest radiograph is normal or demonstrates atypical findings such as nodules, masses, effusions or adenopathy. Finally. prede fined criteria should be established as to when empirical treatment is class ified as a fail ure (eg, five days). Bronchoscopy or other defini tive investigations should then be conducted accordingly.
